These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 8653716)

  • 1. Correspondence re: J.A. Knol et al., Incorporation of 5-bromo-2-deoxyuridine into colorectal liver metastases and liver in patients receiving a 7-day hepatic arterial infusion. Cancer Res., 55: 3687-3691, 1995.
    Kinsella TJ
    Cancer Res; 1996 Jun; 56(11):2677-8. PubMed ID: 8653716
    [No Abstract]   [Full Text] [Related]  

  • 2. Incorporation of 5-bromo-2'-deoxyuridine into colorectal liver metastases and liver in patients receiving a 7-day hepatic arterial infusion.
    Knol JA; Walker SC; Robertson JM; Yang Z; DeRemer S; Stetson PL; Ensminger WD; Lawrence TS
    Cancer Res; 1995 Sep; 55(17):3687-91. PubMed ID: 7641176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The potential superiority of bromodeoxyuridine to iododeoxyuridine as a radiation sensitizer in the treatment of colorectal cancer.
    Lawrence TS; Davis MA; Maybaum J; Mukhopadhyay SK; Stetson PL; Normolle DP; McKeever PE; Ensminger WD
    Cancer Res; 1992 Jul; 52(13):3698-704. PubMed ID: 1617642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iododeoxyuridine (IdUrd) incorporation into DNA of human hematopoietic cells, normal liver and hepatic metastases in man: as a radiosensitizer and as a marker for cell kinetic studies.
    Speth PA; Kinsella TJ; Chang AE; Klecker RW; Belanger K; Smith R; Rowland J; Cupp JE; Collins JM
    Int J Radiat Oncol Biol Phys; 1989 May; 16(5):1247-50. PubMed ID: 2715075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Radiation sensitization of brain neoplasms by haloid analogs of pyrimidine bases].
    Lokshina AM; Pelevina II
    Med Radiol (Mosk); 1973 Mar; 18(3):70-7. PubMed ID: 4267617
    [No Abstract]   [Full Text] [Related]  

  • 6. Divergent patterns of incorporation of bromodeoxyuridine and iododeoxyuridine in human colorectal tumor cell lines.
    Maybaum J; Burton EC; Shelton DA; Jing HW; Dusenbury CE; Ensminger WD; Stetson PL
    Biochem Pharmacol; 1991 Jun; 42(1):131-7. PubMed ID: 1829889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of colorectal cancer--hepatic metastases].
    Makino H; Miyazaki S; Okazumi S; Matsushita K; Miura F; Cho A; Yoshinaga Y; Ohira G; Kudo H; Tohma T; Matsubara K; Gunji Y; Hayashi H; Akutsu N; Ochiai T
    Gan To Kagaku Ryoho; 2002 Nov; 29(12):2447-9. PubMed ID: 12484096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II and pharmacodynamic studies of pyrazine diazohydroxide (NSC 361456) in patients with advanced renal and colorectal cancer.
    Vogelzang NJ; Mani S; Schilsky RL; Ansari RH; Taber D; Rhinehart SN; Garcia JC; Meyer SC; Mick R; Brockstein BE; Stadler WM; Ratain MJ; Vokes EE
    Clin Cancer Res; 1998 Apr; 4(4):929-34. PubMed ID: 9563886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Two cases of resection of synchronous bilobar multiple liver metastases from colorectal cancer after hepatic arterial infusion chemotherapy].
    Shimizu J; Masutani S; Fukunaga M; Ishida H; Kishi K; Takemoto H; Kishimoto T; Nakayama T; Imamura H; Tatsuta M; Furukawa H; Tomotsu K; Inoue Y
    Gan To Kagaku Ryoho; 2004 Oct; 31(11):1665-7. PubMed ID: 15553677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A case report of complete remission of liver metastases from colorectal cancer treated with continuous hepatic arterial infusion].
    Tokunaga T; Sumimura J; Yoshidome K; Fujita S; Tsuji K; Oota F; Tsuboyama N; Nagai I
    Gan To Kagaku Ryoho; 2003 Jul; 30(7):1009-11. PubMed ID: 12894720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extrahepatic biliary stenoses after hepatic arterial infusion (HAI) of floxuridine (FUdR) for liver metastases from colorectal cancer.
    Aldrighetti L; Arru M; Ronzoni M; Salvioni M; Villa E; Ferla G
    Hepatogastroenterology; 2001; 48(41):1302-7. PubMed ID: 11677951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Indication of prophylactic hepatic arterial-infusion chemotherapy after hepatic resection for liver metastases from colorectal cancer].
    Umekita N; Maeshiro T; Miyamoto S; Yamada F; Awane Y
    Gan To Kagaku Ryoho; 1996 Sep; 23(11):1457-60. PubMed ID: 8854779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective incorporation of iododeoxyuridine into DNA of hepatic metastases versus normal human liver.
    Speth PA; Kinsella TJ; Chang AE; Klecker RW; Belanger K; Collins JM
    Clin Pharmacol Ther; 1988 Oct; 44(4):369-75. PubMed ID: 3168389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of base excision repair potentiates iododeoxyuridine-induced cytotoxicity and radiosensitization.
    Taverna P; Hwang HS; Schupp JE; Radivoyevitch T; Session NN; Reddy G; Zarling DA; Kinsella TJ
    Cancer Res; 2003 Feb; 63(4):838-46. PubMed ID: 12591735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxia in relation to vasculature and proliferation in liver metastases in patients with colorectal cancer.
    van Laarhoven HW; Kaanders JH; Lok J; Peeters WJ; Rijken PF; Wiering B; Ruers TJ; Punt CJ; Heerschap A; van der Kogel AJ
    Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):473-82. PubMed ID: 16242253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Continuous hepatic artery infusion chemotherapy and chemoembolization for treatment of patients with liver metastases from colorectal cancer].
    Zhao Y; Wang SM; Zhang J
    Ai Zheng; 2002 Apr; 21(4):421-3. PubMed ID: 12452025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-Bromo-2'-deoxyuridine incorporation into DNA in hepatic VX2 tumor-bearing rabbits.
    Knol JA; Stetson PL; Wagner JG; Johnson NJ; Yang ZM; Prieskorn D; Terrio P; Knutsen CA; Ensminger WD
    J Surg Res; 1989 Aug; 47(2):112-6. PubMed ID: 2755115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hepatic lymph node involvement in patients with synchronous multiple liver metastases of colorectal cancer].
    Ishibashi K; Ohsawa T; Yokoyama M; Ishizuka N; Miyazaki T; Nakada H; Gonda T; Ishida H
    Gan To Kagaku Ryoho; 2006 Nov; 33(12):1834-7. PubMed ID: 17212121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Results of prophylactic hepatic arterial chemotherapy for liver metastases of Dukes C colorectal cancer--correlation with tumoral expression of dihydropyrimidine dehydrogenase, thymidylate synthase, p53, or orotate phosphoribosyl transferase].
    Ishida H; Yamada H; Shirakawa K; Nakada H; Ohsawa T; Takeuchi I; Okada N; Yokoyama M; Inokuma S; Suzuki T; Odaka A; Hoshino T; Murata N; Hashimoto D; Itoyama S; Mori T; Matsumoto Y; Miura T
    Gan To Kagaku Ryoho; 2003 Oct; 30(11):1621-6. PubMed ID: 14619479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic arterial infusion alternating with systemic chemotherapy in patients with non-resectable hepatic metastases from colorectal cancer.
    Kim JC; Kim HC; Lee KH; Yu CS; Kim TW; Chang HM; Ryu MH; Kim JH; Ha HK; Lee MG
    J Gastroenterol Hepatol; 2006 Jun; 21(6):1026-35. PubMed ID: 16724990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.